首页 › 基金 › Propel Bio Management, LLC › ACHV
Propel Bio Management, LLC 对 ACHV 的持仓历史
ACHIEVE LIFE SCIENCE INC · 医疗保健
Propel Bio Management, LLC 在 Q3 2026 的 13F 申报中披露持有 ACHV(ACHIEVE LIFE SCIENCE INC)3,864,148 股,市值约 US$31.3M,约占其申报组合的 16.57%,在其申报持仓中市值排名第 2 位。 Propel Bio Management, LLC 最近 11 个申报季度中有 11 个季度披露了 ACHV 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Propel Bio Management, LLC 对 ACHV 的持仓演变
Propel Bio Management, LLC 于 Q1 2024 首次披露 ACHV 持仓:2,453,092 股(约 US$11.1M)。 该持仓在 Q3 2026 达到峰值 3,864,148 股,市值约 US$31.3M。 在 11 次申报中,Propel Bio Management, LLC 2 次增持、2 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 3,864,148 股、市值约 US$31.3M,环比减持 -169,870 股。。 持仓曾出现大幅变动:Q2 2025 增持约 151% (随后一个季度股价上涨 39%)、Q3 2025 减持约 38% (随后一个季度股价上涨 58%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 2.45M | $11.15M | 新进 |
| Q2 2024 | 2.45M | $11.53M | 持有 |
| Q3 2024 | 2.45M | $11.63M | 持有 |
| Q4 2024 | 2.45M | $8.63M | 持有 |
| Q1 2025 | 2.45M | $6.55M | 持有 |
| Q2 2025 | 6.15M | $13.91M | 增持 |
| Q3 2025 | 3.79M | $11.93M | 减持 |
| Q4 2025 | 3.79M | $18.82M | 持有 |
| Q1 2026 | 3.79M | $11.37M | 持有 |
| Q2 2026 | 4.03M | $26.34M | 增持 |
| Q3 2026 | 3.86M | $31.26M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ACHV 与 13F 数据
ACHV(ACHIEVE LIFE SCIENCE INC)属于医疗保健行业。我们追踪的基金中还有 68 只申报持有 ACHV,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$49.7M), TPG GP A, LLC (US$44.9M), venBio Partners LLC (US$38.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ACHV 的基金
- Frazier Life Sciences Management, L.P. 7.61M 股 · $49.72M · Q2 2026
- TPG GP A, LLC 6.88M 股 · $44.91M · Q2 2026
- venBio Partners LLC 5.91M 股 · $38.62M · Q2 2026
- Logos Global Management LP 5.42M 股 · $35.43M · Q2 2026
- Paradigm Biocapital Advisors LP 4.95M 股 · $32.34M · Q2 2026
- Vivo Capital, LLC 2.75M 股 · $22.26M · Q3 2026
- Venrock Adviser, LLC 2.75M 股 · $17.96M · Q2 2026
- Simplify Asset Management Inc. 932.11K 股 · $7.54M · Q3 2026
- Spruce Street Capital LP 736.64K 股 · $4.81M · Q2 2026
- Blue Owl Capital Holdings LP 412.65K 股 · $3.34M · Q3 2026
- KVP Capital Advisors, LP 462.36K 股 · $3.02M · Q2 2026
更多关于 Propel Bio Management, LLC
常见问题
How long has Propel Bio Management, LLC held ACHV?
Propel Bio Management, LLC has disclosed ACHV holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Propel Bio Management, LLC's current position in ACHV?
As of Q3 2026, Propel Bio Management, LLC holds 3.86M shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $31.26M, representing 16.57% of its reported portfolio and ranking #2.
Has Propel Bio Management, LLC been buying or selling ACHV?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in ACHV. The position peaked in Q3 2026 at 3.86M shares.
Which other funds hold ACHV?
Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., TPG GP A, LLC, venBio Partners LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.